FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009923883> ?p ?o ?g. }

• W2009923883 endingPage "148" @default.
• W2009923883 startingPage "147" @default.
• W2009923883 abstract "Clinical EndocrinologyVolume 73, Issue 2 p. 147-148 COMMENTARY Prolactinomas and pregnancy Mark E. Molitch, Mark E. Molitch Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USASearch for more papers by this author Mark E. Molitch, Mark E. Molitch Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USASearch for more papers by this author First published: 21 July 2010 https://doi.org/10.1111/j.1365-2265.2010.03823.xCitations: 4 Mark E. Molitch, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave., Suite 530, Chicago, IL 60611, USA. Tel.: +1 312 503 4130; Fax: +1 312 926 8693; E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Lebbe, M., Hubinont, C., Bernard, P. et al. (2010) Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clinical Endocrinology, 73, 230–236. 2 Krupp, P. & Monka, C. (1987) Bromocriptine in pregnancy: safety aspects. Klinische Wochenschrift, 65, 823–827. 3 Krupp, P., Monka, C. & Richter, K. (1988) The safety aspects of infertility treatments. Program of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, October, 1988. 4 Canfield, M.A., Honein, M.A., Yuskiv, N. et al. (2006) National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001. Birth Defects Research. Part A, Clinical and Molecular Teratology, 76, 747–756. 5 Martin, J.A., Kung, H.-C., Mathews, T.J. et al. (2008) Annual summary of vital statistics: 2006. Pediatrics, 121, 788–801. 6 Webster, J., Piscitelli, G., Polli, A. et al. (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. New England Journal of Medicine, 331, 904–909. 7 Ferrari, C., Paracchi, A., Mattei, A.M. et al. (1992) Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinologica, 126, 489–494. 8 Robert, E., Musatti, L., Piscitelli, G. et al. (1996) Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reproductive Toxicology, 10, 333–337. 9 Ciccarelli, E., Grottoli, S., Razzzore, P. et al. (1997) Long-term treatment with cabergoline, a new long-lasting ergoline derivative, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy. Journal of Endocrinological Investigation, 20, 547–551. 10 Cannavò, S., Curtò, L., Squadrito, S. et al. (1999) Cabegoline: a first-choice treatment in patients with previously untreatd prolactin-secreting pituitary adenoma. Journal of Endocrinological Investigation, 22, 354–359. 11 Verhelst, J., Abs, R., Maiter, D. et al. (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. Journal of Clinical Endocrinology and Metabolism, 84, 2518–2522. 12 Ricci, E., Parazzini, F., Motta, T. et al. (2002) Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reproductive Toxicology, 16, 791–793. 13 Bronstein, M.D. (2005) Prolactinomas and pregnancy. Pituitary, 8, 31–38. 14 Colao, A., Abs, R., Bárcena, D.G. et al. (2008) Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology, 68, 66–71. 15 Ono, M., Miki, N., Amano, K. et al. (2010) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. Journal of Clinical Endocrinology and Metabolism, 95, 2672–2679. 16 Raymond, J.P., Goldstein, E., Konopka, P. et al. (1985) Follow-up of children born of bromocriptine-treated mothers. Hormone Research, 22, 239–246. 17 Webster, J. (1996) A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Safety, 14, 228–238. 18 Molitch, M.E. (2006) Pituitary disorders during pregnancy. Endocrinology and Metabolism Clinics of North America, 35, 99–116. 19 Cohen-Kerem, R., Railton, C., Orfen, D. et al. (2005) Pregnancy outcome following non-obstetric surgical intervention. American Journal of Surgery, 190, 467–473. Citing Literature Volume73, Issue2August 2010Pages 147-148 ReferencesRelatedInformation" @default.
• W2009923883 created "2016-06-24" @default.
• W2009923883 creator A5060451560 @default.
• W2009923883 date "2010-07-21" @default.
• W2009923883 modified "2023-10-18" @default.
• W2009923883 title "Prolactinomas and Pregnancy" @default.
• W2009923883 cites W1967484895 @default.
• W2009923883 cites W1979270155 @default.
• W2009923883 cites W1987858801 @default.
• W2009923883 cites W1992388781 @default.
• W2009923883 cites W1995318100 @default.
• W2009923883 cites W2004096655 @default.
• W2009923883 cites W2011863772 @default.
• W2009923883 cites W2013076830 @default.
• W2009923883 cites W2040892630 @default.
• W2009923883 cites W2050434570 @default.
• W2009923883 cites W2058731555 @default.
• W2009923883 cites W2081532357 @default.
• W2009923883 cites W2134198313 @default.
• W2009923883 cites W2153683302 @default.
• W2009923883 cites W2161513867 @default.
• W2009923883 cites W2162101935 @default.
• W2009923883 cites W2171744517 @default.
• W2009923883 doi "https://doi.org/10.1111/j.1365-2265.2010.03823.x" @default.
• W2009923883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20550542" @default.
• W2009923883 hasPublicationYear "2010" @default.
• W2009923883 type Work @default.
• W2009923883 sameAs 2009923883 @default.
• W2009923883 citedByCount "11" @default.
• W2009923883 countsByYear W20099238832012 @default.
• W2009923883 countsByYear W20099238832013 @default.
• W2009923883 countsByYear W20099238832014 @default.
• W2009923883 countsByYear W20099238832015 @default.
• W2009923883 countsByYear W20099238832017 @default.
• W2009923883 countsByYear W20099238832018 @default.
• W2009923883 countsByYear W20099238832023 @default.
• W2009923883 crossrefType "journal-article" @default.
• W2009923883 hasAuthorship W2009923883A5060451560 @default.
• W2009923883 hasConcept C126322002 @default.
• W2009923883 hasConcept C134018914 @default.
• W2009923883 hasConcept C143998085 @default.
• W2009923883 hasConcept C161191863 @default.
• W2009923883 hasConcept C2778805511 @default.
• W2009923883 hasConcept C2779064019 @default.
• W2009923883 hasConcept C2779234561 @default.
• W2009923883 hasConcept C2779832395 @default.
• W2009923883 hasConcept C29456083 @default.
• W2009923883 hasConcept C41008148 @default.
• W2009923883 hasConcept C54355233 @default.
• W2009923883 hasConcept C71315377 @default.
• W2009923883 hasConcept C71924100 @default.
• W2009923883 hasConcept C86803240 @default.
• W2009923883 hasConceptScore W2009923883C126322002 @default.
• W2009923883 hasConceptScore W2009923883C134018914 @default.
• W2009923883 hasConceptScore W2009923883C143998085 @default.
• W2009923883 hasConceptScore W2009923883C161191863 @default.
• W2009923883 hasConceptScore W2009923883C2778805511 @default.
• W2009923883 hasConceptScore W2009923883C2779064019 @default.
• W2009923883 hasConceptScore W2009923883C2779234561 @default.
• W2009923883 hasConceptScore W2009923883C2779832395 @default.
• W2009923883 hasConceptScore W2009923883C29456083 @default.
• W2009923883 hasConceptScore W2009923883C41008148 @default.
• W2009923883 hasConceptScore W2009923883C54355233 @default.
• W2009923883 hasConceptScore W2009923883C71315377 @default.
• W2009923883 hasConceptScore W2009923883C71924100 @default.
• W2009923883 hasConceptScore W2009923883C86803240 @default.
• W2009923883 hasIssue "2" @default.
• W2009923883 hasLocation W20099238831 @default.
• W2009923883 hasLocation W20099238832 @default.
• W2009923883 hasOpenAccess W2009923883 @default.
• W2009923883 hasPrimaryLocation W20099238831 @default.
• W2009923883 hasRelatedWork W152287838 @default.
• W2009923883 hasRelatedWork W156942242 @default.
• W2009923883 hasRelatedWork W1919995557 @default.
• W2009923883 hasRelatedWork W1970233618 @default.
• W2009923883 hasRelatedWork W2078493674 @default.
• W2009923883 hasRelatedWork W2142549396 @default.
• W2009923883 hasRelatedWork W2147564915 @default.
• W2009923883 hasRelatedWork W2799705132 @default.
• W2009923883 hasRelatedWork W4235106691 @default.
• W2009923883 hasRelatedWork W4317038164 @default.
• W2009923883 hasVolume "73" @default.
• W2009923883 isParatext "false" @default.
• W2009923883 isRetracted "false" @default.
• W2009923883 magId "2009923883" @default.
• W2009923883 workType "article" @default.